The Journal of Immunology, Vol 153, Issue 6 2470-2478, Copyright © 1994 by American Association of Immunologists

ARTICLES

Resistance of CTL to perforin-mediated lysis. Evidence for a lymphocyte membrane protein interacting with perforin

C Muller and J Tschopp
Institute of Biochemistry, University of Lausanne, Epalinges, Switzerland.

Cytotoxic T lymphocytes are highly resistant to killing by their own cytolytic protein perforin. We have investigated the molecular basis of this self-protection mechanism. CTL withstood high dosages of perforin, when complete lysis was obtained with various tumor target cell lines. A peptide-specific CTL clone readily lysed tumor targets presenting the peptide, but was unable to kill the peptide-presenting CTL in spite of equal degranulation. With streptolysin O, a pore-forming lytic protein of bacterial origin, no difference in susceptibility between the various targets was detected. Perforin was radioactively labeled by using the Bolton and Hunter method without any loss of its lytic activity. Experiments performed at 4 degrees C revealed that, on all of the cells studied, binding of the labeled perforin to the membrane is reversible and strictly Ca(2+)-dependent. After a short exposure to 37 degrees C, perforin was no longer dissociated from cell membranes by EDTA. Although no correlation between susceptibility and the extent of perforin binding was detected, differences in the conformation of membrane-bound perforin were observed. Perforin adsorbed to resistant cells was cleaved by trypsin into a 55-kDa (C-terminal) and a 10- to 15- kDa (N-terminal) fragment, whereas this cleavage was not found on tumor cell-bound perforin. A portion of perforin was included in the Triton X- 114 detergent phase at 4 degrees C on resistant CTLs only. Our results are compatible with the notion that a protective molecule, specifically expressed on CTLs, interacts with perforin, thereby rendering it lytically inactive.

This article has been cited by other articles:

				K. Baran, A. Ciccone, C. Peters, H. Yagita, P. I. Bird, J. A. Villadangos, and J. A. Trapani Cytotoxic T Lymphocytes from Cathepsin B-deficient Mice Survive Normally in Vitro and in Vivo after Encountering and Killing Target Cells J. Biol. Chem., October 13, 2006; 281(41): 30485 - 30491. [Abstract] [Full Text] [PDF]

				T. Azuma, T. Otsuki, K. Kuzushima, C. J. Froelich, S. Fujita, and M. Yasukawa Myeloma Cells Are Highly Sensitive to the Granule Exocytosis Pathway Mediated by WT1-Specific Cytotoxic T Lymphocytes Clin. Cancer Res., November 1, 2004; 10(21): 7402 - 7412. [Abstract] [Full Text] [PDF]

				K. N. Balaji, N. Schaschke, W. Machleidt, M. Catalfamo, and P. A. Henkart Surface Cathepsin B Protects Cytotoxic Lymphocytes from Self-destruction after Degranulation J. Exp. Med., August 19, 2002; 196(4): 493 - 503. [Abstract] [Full Text] [PDF]

				M. Q. Zhao, M. K. Amir, W. R. Rice, and R. I. Enelow Type II Pneumocyte-CD8+ T-Cell Interactions . Relationship between Target Cell Cytotoxicity and Activation Am. J. Respir. Cell Mol. Biol., September 1, 2001; 25(3): 362 - 369. [Abstract] [Full Text] [PDF]

				C. Lehmann, M. Zeis, N. Schmitz, and L. Uharek Impaired binding of perforin on the surface of tumor cells is a cause of target cell resistance against cytotoxic effector cells Blood, July 15, 2000; 96(2): 594 - 600. [Abstract] [Full Text] [PDF]

				H.-M. Lee, T. L. Timme, and T. C. Thompson Resistance to Lysis by Cytotoxic T Cells: A Dominant Effect in Metastatic Mouse Prostate Cancer Cells Cancer Res., April 1, 2000; 60(7): 1927 - 1933. [Abstract] [Full Text]

				C. Berthou, J.-F. Bourge, Y. Zhang, A. Soulie, D. Geromin, Y. Denizot, F. Sigaux, and M. Sasportes Interferon-gamma -induced membrane PAF-receptor expression confers tumor cell susceptibility to NK perforin-dependent lysis Blood, April 1, 2000; 95(7): 2329 - 2336. [Abstract] [Full Text] [PDF]

				M. J. Raftery, C. K. Behrens, A. Muller, P. H. Krammer, H. Walczak, and G. Schonrich Herpes Simplex Virus Type 1 Infection of Activated Cytotoxic T Cells: Induction of Fratricide as a Mechanism of Viral Immune Evasion J. Exp. Med., October 18, 1999; 190(8): 1103 - 1114. [Abstract] [Full Text] [PDF]

				M. H. Vermeer, F. A.M.J. Geelen, J. A. Kummer, C. J.L.M. Meijer, and R. Willemze Expression of Cytotoxic Proteins by Neoplastic T Cells in Mycosis Fungoides Increases with Progression from Plaque Stage to Tumor Stage Disease Am. J. Pathol., April 1, 1999; 154(4): 1203 - 1210. [Abstract] [Full Text] [PDF]

				C. H. Bird, V. R. Sutton, J. Sun, C. E. Hirst, A. Novak, S. Kumar, J. A. Trapani, and P. I. Bird Selective Regulation of Apoptosis: the Cytotoxic Lymphocyte Serpin Proteinase Inhibitor 9 Protects against Granzyme B-Mediated Apoptosis without Perturbing the Fas Cell Death Pathway Mol. Cell. Biol., November 1, 1998; 18(11): 6387 - 6398. [Abstract] [Full Text]

				R. V. Talanian, X. Yang, J. Turbov, P. Seth, T. Ghayur, C. A. Casiano, K. Orth, and C. J. Froelich Granule-mediated Killing: Pathways for Granzyme B-initiated Apoptosis J. Exp. Med., October 20, 1997; 186(8): 1323 - 1331. [Abstract] [Full Text] [PDF]

				J.J. Oudejans, N.M. Jiwa, J.A. Kummer, G.J. Ossenkoppele, P. van Heerde, J.W. Baars, Ph.M. Kluin, J.C. Kluin-Nelemans, P.J. van Diest, J.M. Middeldorp, et al. Activated Cytotoxic T Cells as Prognostic Marker in Hodgkin's Disease Blood, February 15, 1997; 89(4): 1376 - 1382. [Abstract] [Full Text] [PDF]